The authors would like to correct an error in panel A of [Figure 1](#ppat-1004544-g001){ref-type="fig"}. Some of the western blot panels depicted in [Figure 1A](#ppat-1004544-g001){ref-type="fig"} were switched with those in [Figure 1B](#ppat-1004544-g001){ref-type="fig"} during assembly of the final figure. The authors have replaced the Western blots in [Figure 1A](#ppat-1004544-g001){ref-type="fig"} with a set of panels from an independent experiment ran under the same conditions. Please see the corrected version of [Figure 1](#ppat-1004544-g001){ref-type="fig"} here.

![Regulation of the expression of PROX1 and IL3Rα by KSHV in blood vs. lymphatic-lineage endothelial cells.\
(A) KSHV upregulated PROX1 in BECs and HUVECs, but downregulated PROX1 in LECs based on quantitative real-time RT-PCR (qRT-PCR) and western blot analyses. Latency-associated nuclear antigen (LANA) was used to confirm KSHV-infection and β-actin for equal loading in western analyses. (B) IL3Rα was comparably upregulated by KSHV in the three cell types determined by qRT-PCR and western blot analyses. (C) Expression of IL3Rβ, IL5Rα and GM-CSFRα in BECs by KSHV infection was determined by qRT-PCR. (D) Immunohistochemistry analysis showed prominent expression of IL3Rα in KS tumor cells (arrow-marked) in the skin of a HIV-positive patient. CTR, a control skin section from a normal neonatal foreskin; KS, Kaposi sarcoma tumor section from a HIV-positive individual.](ppat.1004544.g001){#ppat-1004544-g001}
